研究者業績
基本情報
研究分野
1論文
85-
Journal of Medical Systems 50(1) 2026年1月29日Abstract Heart rate variability (HRV) is a well-established, noninvasive measure of autonomic nervous system activity and is associated with clinical outcomes. Although real-time monitoring of HRV is valuable in clinical practice, its effectiveness is often compromised by major challenges: high inter-individual variability and frequent data contamination from procedural artifacts. To address these challenges, we developed and validated a computational framework for robust and personalized real-time HRV analysis oriented toward clinical application. The framework performs simultaneous analysis and visualization of both time- and frequency-domain HRV indices and incorporates an adaptive alert algorithm that personalizes alert thresholds using the interquartile range of each patient’s own data. A workflow-integrated mechanism for manually annotating and excluding artifact-prone periods prevents procedural artifacts from skewing the statistical baselines, and a multi-scale visualization module provides a unified view of short-term fluctuations and long-term trends. While existing HRV tools are powerful for research or offline analysis, they often lack the integration of personalized alerting and workflow-oriented artifact management needed for bedside care. The proposed system uniquely combines personalized alerting, care-linked artifact exclusion, and multi-scale bedside visualization within a single real-time software package. The framework was validated using open-access electrocardiogram (ECG) databases and synthetic noise-contaminated signals, confirming robust R-wave detection across pediatric and adult recordings and under low signal-to-noise conditions. In addition, the framework was operationally validated at the bedside using ECG data from 24 newborn patients. By systematically addressing the core challenges of personalization and artifact management in a clinically integrated manner, this work represents a significant step toward translating real-time HRV analysis into routine vital sign management and, ultimately, improved patient outcomes.
MISC
24-
日本小児腎不全学会雑誌 31 303-305 2011年7月 査読有り1946年にPotterが両側性腎無形成と特徴的な顔貌を呈する症候群を記載して以来、Potter sequenceの報告は数多くみられるが、長期生存したという報告は調べた限りではみられない。今回著者等は、母体が高度の羊水過少をきたし、児のPotter sequenceが疑われる症例に対して、妊娠継続と肺低形成予防を目的に頻回の人工羊水注入療法を行い出生した2例を経験した。両例とも出生後は腹膜透析を必要としたが、肺低形成は軽度であり、人工羊水注入療法はPotter sequence児の生命予後を改善させる可能性があると考えられた。
-
日本未熟児新生児学会雑誌 = Journal of Japan Society for Premature and Newborn Medicine 23(2) 65-71 2011年6月15日
-
JOURNAL OF PHYSIOLOGICAL SCIENCES 59 132-132 2009年